Literature DB >> 2402423

Topical anesthetic abuse.

G O Rosenwasser1, S Holland, S C Pflugfelder, M Lugo, D G Heidemann, W W Culbertson, H Kattan.   

Abstract

Topical ocular anesthetic abuse is a serious disorder causing keratitis and persistent epithelial defects. It may be the result of either prescription by the patient's eye care practitioner, theft from the practitioner's office, or occult additives in therapeutic medications. The authors report observations of six individuals suffering from this disorder which suggest that persistent epithelial defects, corneal stromal ring infiltrates, disproportionate pain, and prescription or nonprescription substance abuse may be factors involved. Penetrating keratoplasty was required to treat corneal perforation in two patients, and permanent corneal structural damage was noted in two eyes. Two eyes had a relentless downhill course culminating in enucleation. Because five of the six patients were diagnosed and treated as having presumed Acanthamoeba keratitis during the course of their disease, topical ocular anesthetic use should be included in the differential diagnosis of chronic keratitis and may masquerade as Acanthamoeba keratitis. The authors believe that practitioners should not prescribe or dispense topical anesthetics and should avoid clinical settings which provide an opportunity for the theft of topical ocular anesthetics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402423     DOI: 10.1016/s0161-6420(90)32458-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Recurrent corneal ulceration as late complication of toxic keratitis.

Authors:  Barry N Wasserman; Robert P Liss; S H Santander
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Mitsuru Sawa; Kazunori Miyata; Takaaki Matsui; Kyoko Shigeta
Journal:  Jpn J Ophthalmol       Date:  2011-11-11       Impact factor: 2.447

3.  Effects of 5% sodium chloride ophthalmic ointment on thickness and morphology of the normal canine cornea.

Authors:  Michelle Samuel; Sara M Thomasy; Allison S Calderon; Philip H Kass; Keith Collins; Christopher J Murphy
Journal:  Vet Ophthalmol       Date:  2018-06-21       Impact factor: 1.644

4.  Toxic keratopathy associated with topical abuse of low-concentration anesthetics: A report of two cases.

Authors:  Hsin-Ching Shen; Yu-Chih Hou
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

5.  Management of Ocular Trauma in Emergency (MOTE) Trial: A pilot randomized double-blinded trial comparing topical amethocaine with saline in the outpatient management of corneal trauma.

Authors:  Joseph Y S Ting; Kenneth J Barns; John L Holmes
Journal:  J Emerg Trauma Shock       Date:  2009-01

6.  Keratopathy due to ophthalmic drug abuse with corneal melting and perforation presenting as Mooren-like ulcer: A case report.

Authors:  Hui Wu; Yuan Hu; Xiao-Ru Shi; Feihong Xu; Chun-Ying Jiang; Rong Huang; Hui Jia
Journal:  Exp Ther Med       Date:  2016-04-27       Impact factor: 2.447

7.  Topical proparacaine abuse resulting in evisceration.

Authors:  Adnan Aksoy; Ahmet Metin Başkan; Lokman Aslan; Murat Aslankurt
Journal:  BMJ Case Rep       Date:  2013-04-22

8.  Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome.

Authors:  Humaira Ansari; Laurence Weinberg; Narelle Spencer
Journal:  BMJ Case Rep       Date:  2013-09-13

9.  Synthetic neurotensin analogues are nontoxic analgesics for the rabbit cornea.

Authors:  Charles Kim; Denise Barbut; Murk H Heinemann; Gavril Pasternak; Mark I Rosenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-13       Impact factor: 4.799

Review 10.  An overview of home tonometry and telemetry for intraocular pressure monitoring in humans.

Authors:  Edward Yung; Valerie Trubnik; L Jay Katz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.